Light therapy for preventing seasonal affective disorder
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Seasonal affective disorder (SAD) is a seasonal pattern of recurrent major depressive episodes that most commonly occurs during autumn or winter and remits in spring. The prevalence of SAD ranges from 1.5% to 9%, depending on latitude. The predictable seasonal aspect of SAD provides a promising opportunity for prevention. This review - one of four reviews on efficacy and safety of interventions to prevent SAD - focuses on light therapy as a preventive intervention. Light therapy is a non-pharmacological treatment that exposes people to artificial light. Mode of delivery and form of light vary. OBJECTIVES: To assess the efficacy and safety of light therapy (in comparison with no treatment, other types of light therapy, second-generation antidepressants, melatonin, agomelatine, psychological therapies, lifestyle interventions and negative ion generators) in preventing SAD and improving patient-centred outcomes among adults with a history of SAD. SEARCH METHODS: We searched Ovid MEDLINE (1950- ), Embase (1974- ), PsycINFO (1967- ) and the Cochrane Central Register of Controlled Trials (CENTRAL) to 19 June 2018. An earlier search of these databases was conducted via the Cochrane Common Mental Disorders Controlled Trial Register (CCMD-CTR) (all years to 11 August 2015). Furthermore, we searched the Cumulative Index to Nursing and Allied Health Literature, Web of Science, the Cochrane Library, the Allied and Complementary Medicine Database and international trial registers (to 19 June 2018). We also conducted a grey literature search and handsearched the reference lists of included studies and pertinent review articles. SELECTION CRITERIA: For efficacy, we included randomised controlled trials (RCTs) on adults with a history of winter-type SAD who were free of symptoms at the beginning of the study. For adverse events, we also intended to include non-randomised studies. We intended to include studies that compared any type of light therapy (e.g. bright white light, administered by visors or light boxes, infrared light, dawn stimulation) versus no treatment/placebo, second-generation antidepressants, psychological therapies, melatonin, agomelatine, lifestyle changes, negative ion generators or another of the aforementioned light therapies. We also planned to include studies that looked at light therapy in combination with any comparator intervention. DATA COLLECTION AND ANALYSIS: Two review authors screened abstracts and full-text publications, independently abstracted data and assessed risk of bias of included studies. MAIN RESULTS: We identified 3745 citations after de-duplication of search results. We excluded 3619 records during title and abstract review. We assessed 126 full-text papers for inclusion in the review, but only one study providing data from 46 people met our eligibility criteria. The included RCT had methodological limitations. We rated it as having high risk of performance and detection bias because of lack of blinding, and as having high risk of attrition bias because study authors did not report reasons for dropouts and did not integrate data from dropouts into the analysis.The included RCT compared preventive use of bright white light (2500 lux via visors), infrared light (0.18 lux via visors) and no light treatment. Overall, white light and infrared light therapy reduced the incidence of SAD numerically compared with no light therapy. In all, 43% (6/14) of participants in the bright light group developed SAD, as well as 33% (5/15) in the infrared light group and 67% (6/9) in the non-treatment group. Bright light therapy reduced the risk of SAD incidence by 36%; however, the 95% confidence interval (CI) was very broad and included both possible effect sizes in favour of bright light therapy and those in favour of no light therapy (risk ratio (RR) 0.64, 95% CI 0.30 to 1.38; 23 participants, very low-quality evidence). Infrared light reduced the risk of SAD by 50% compared with no light therapy, but the CI was also too broad to allow precise estimations of effect size (RR 0.50, 95% CI 0.21 to 1.17; 24 participants, very low-quality evidence). Comparison of both forms of preventive light therapy versus each other yielded similar rates of incidence of depressive episodes in both groups (RR 1.29, 95% CI 0.50 to 3.28; 29 participants, very low-quality evidence). Reasons for downgrading evidence quality included high risk of bias of the included study, imprecision and other limitations, such as self-rating of outcomes, lack of checking of compliance throughout the study duration and insufficient reporting of participant characteristics.Investigators provided no information on adverse events. We could find no studies that compared light therapy versus other interventions of interest such as second-generation antidepressants, psychological therapies, melatonin or agomelatine. AUTHORS' CONCLUSIONS: Evidence on light therapy as preventive treatment for people with a history of SAD is limited
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Golden, R. N., Gaynes, B. N., Ekstrom, R. D., Hamer, R. M., Jacobsen, F. M., Suppes, T., Wisner, K. L., & Nemeroff, C. B. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.4.656 · Cited by 896
Self-citationLight Therapy for Seasonal and Nonseasonal Depression: Efficacy, Protocol, Safety, and Side Effects
Terman, M., & Terman, J. S. (2005) · CNS Spectrums · doi:10.1017/s1092852900019611 · Cited by 546
Lam, R. W., Levitt, A. J., Levitan, R. D., Enns, M. W., Morehouse, R., Michalak, E. E., & Tam, E. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.805 · Cited by 232
Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues
Ciarleglio, C. M., Resuehr, H. E. S., & McMahon, D. G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.036 · Cited by 151
The chronobiology and neurobiology of winter seasonal affective disorder
Levitan, R. D. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.3/rlevitan · Cited by 149
Circadian Rhythms, Melatonin and Depression
A. Quera Salva, M., Hartley, S., Barbot, F., C. Alvarez, J., Lofaso, F., & Guilleminault, C. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796197188 · Cited by 100
Rohan, K. J., Roecklein, K. A., Tierney Lindsey, K., Johnson, L. G., Lippy, R. D., Lacy, T. J., & Barton, F. B. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.489 · Cited by 87
The phototherapy light visor: more to it than meets the eye
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1197 · Cited by 58
Light therapy for seasonal affective disorder in primary care: Randomised controlled trial
Wileman, S. M., Eagles, J. M., Andrew, J. E., Howie, F. L., Cameron, I. M., McCormack, K., & Naji, S. A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.4.311 · Cited by 51
Cited by
Circadian disruption and human health
Fishbein, A. B., Knutson, K. L., & Zee, P. C. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148286 · Cited by 468
Maj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., Demyttenaere, K., McIntyre, R. S., Widiger, T., & Wittchen, H. (2020) · World Psychiatry · doi:10.1002/wps.20771 · Cited by 435
Seasonal variations in cardiovascular disease
Stewart, S., Keates, A. K., Redfern, A., & McMurray, J. J. V. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.76 · Cited by 328
Bright light as a personalized precision treatment of mood disorders
Maruani, J., & Geoffroy, P. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00085 · Cited by 112
Geoffroy, P. A., Schroder, C. M., Reynaud, E., & Bourgin, P. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2019.101213 · Cited by 100
Association of Postpartum Depression with Maternal Suicide: A Nationwide Population-Based Study
Lee, Y.-L., Tien, Y., Bai, Y.-S., Lin, C.-K., Yin, C.-S., Chung, C.-H., Sun, C.-A., Huang, S.-H., Huang, Y.-C., Chien, W.-C., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095118 · Cited by 61
“In research on the use of light therapy for preventing seasonal affective disorder, a lower prevalence of winter depression in lower-latitude regions was found [29].”
BackgroundZhou, T.-H., Dang, W.-M., Ma, Y.-T., Hu, C.-Q., Wang, N., Zhang, G.-Y., Wang, G., Shi, C., Zhang, H., Guo, B., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.038 · Cited by 53
Efficacy of bright light therapy in bipolar depression
Yorguner Kupeli, N., Bulut, N. S., Carkaxhiu Bulut, G., Kurt, E., & Kora, K. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.020 · Cited by 51
Mayer, J. S., Hees, K., Medda, J., Grimm, O., Asherson, P., Bellina, M., Colla, M., Ibáñez, P., Koch, E., Martinez-Nicolas, A., et al. (2018) · Trials · doi:10.1186/s13063-017-2426-1 · Cited by 48
Melatonin and agomelatine for preventing seasonal affective disorder
Kaminski-Hartenthaler, A., Nussbaumer, B., Forneris, C. A., Morgan, L. C., Gaynes, B. N., Sonis, J. H., Greenblatt, A., Wipplinger, J., Lux, L. J., Winkler, D., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011271.pub2 · Cited by 39
Self-citationPilkington, K., & Wieland, L. S. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03038-8 · Cited by 31
Hurd, D., Herrera, M., Brant, J. M., Coombs, N. C., & Arzubi, E. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0063 · Cited by 16
Geoffroy, P. A., Abbassi, E. M. B. E., Maruani, J., Etain, B., Lejoyeux, M., Amad, A., Courtet, P., Dubertret, C., Gorwood, P., Vaiva, G., et al. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.09.27.1 · Cited by 16
Melatonin and agomelatine for preventing seasonal affective disorder
Kaminski-Hartenthaler, A., Nussbaumer, B., Forneris, C. A., Morgan, L. C., Gaynes, B. N., Sonis, J. H., Greenblatt, A., Wipplinger, J., Lux, L. J., Hofmann, J., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011271 · Cited by 11
Self-citationLight therapy in medicine: where do we stand?
Oyama, Y., Witowski, A., Adamzik, M., Bartels, K., & de la Garza Eckle, T. (2026) · Annals of Translational Medicine · doi:10.21037/atm-2026-0041
Metadata
- Authors
- Nussbaumer, B., Kaminski-Hartenthaler, A., Forneris, C. A., Morgan, L. C., Sonis, J. H., Gaynes, B. N., Greenblatt, A., Wipplinger, J., Lux, L. J., Winkler, D., Van Noord, M. G., Hofmann, J., & Gartlehner, G.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-11-08
- Volume
- 3
- Issue
- 11
- Pages
- CD011269-CD011269
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2140140017
- Cited by
- 115
- References
- 12
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.